Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
BPMC holding history
Blueprint Medicines Corp in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BPMC overviewAll 13F holders of BPMCFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −6,512−100.0% | Sold out | Holders |
| Q3 2024 | 6,512 | $602.4K | <0.1% | +465+7.7% | Added | Holders |
| Q2 2024 | 6,047 | $651.7K | <0.1% | −569−8.6% | Reduced | Holders |
| Q1 2024 | 6,616 | $627.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 6,616 | $610.3K | <0.1% | +1,249+23.3% | Added | Holders |
| Q3 2023 | 5,367 | $269.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 5,367 | $339.2K | <0.1% | +5,367 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −3,530−100.0% | Sold out | Holders |
| Q3 2022 | 3,530 | $233.0K | <0.1% | +3,530 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −3,851−100.0% | Sold out | Holders |
| Q1 2022 | 3,851 | $246.0K | <0.1% | −2,105−35.3% | Reduced | Holders |
| Q4 2021 | 5,956 | $638.0K | <0.1% | +401+7.2% | Added | Holders |
| Q3 2021 | 5,555 | $571.0K | <0.1% | +2,486+81.0% | Added | Holders |
| Q2 2021 | 3,069 | $270.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,069 | $298.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.